Form 4: Quest Diagnostics Director, Gary M. Pfeiffer, Reports Acquisition and Disposal of Common Stock

Director Gary M. Pfeiffer reports acquiring 1,482 shares of Quest Diagnostics common stock through restricted share units and disposing of an unspecified amount.

Summary

• On May 16, 2024, Gary M. Pfeiffer, a director of Quest Diagnostics Inc., reported a transaction involving the company's common stock.
• Pfeiffer acquired 1,482 shares through an award of restricted share units.
• He also disposed of an unspecified amount of shares.
• Following these transactions, Pfeiffer beneficially owns 28,916 shares, which includes shares acquired via dividend reinvestment since the last filing.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it primarily reports transactions without expressing a clear positive or negative outlook.

Positives

• The acquisition of shares through restricted share units could be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The disposal of shares by a director could be interpreted negatively by some investors, although the quantity is not specified.

Risks

• The document does not explicitly mention any risks.
• However, any disposal of shares by a company director could be perceived as a potential risk factor by investors.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• The reported transactions may influence investor sentiment regarding Quest Diagnostics.
• Transparency in insider trading activity helps maintain investor confidence.

Key Dates